Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND)
Status:
Completed
Trial end date:
2020-12-30
Target enrollment:
Participant gender:
Summary
Primary Objective:
Assess the long term safety of sarilumab in patients with rheumatoid arthritis.
Secondary Objective:
Assess the long term efficacy of sarilumab in patients with rheumatoid arthritis.